ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,682Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 973

$517K Total Retail Price of All Prescriptions

Rank: 136 out of 973

532 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 532 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 532 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 9,439 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 623 509 1 1
LEVOTHYROXINE SODIUM 538 452 2 2
FUROSEMIDE 394 343 3 6
AMLODIPINE BESYLATE 341 310 4 7
LISINOPRIL 276 259 5 3
HYDROCODONE-ACETAMINOPHEN 272 210 S3 6 4
WARFARIN SODIUM 272 249 6 10
OMEPRAZOLE 229 207 8 5
METFORMIN HCL 222 156 9 8
METOPROLOL SUCCINATE 216 193 10 17
POTASSIUM CHLORIDE 211 203 11 9
ATORVASTATIN CALCIUM 204 185 12 15
GABAPENTIN 202 144 13 12
MELOXICAM 188 154 14 23
CITALOPRAM HBR 185 144 15 14
TRAMADOL HCL 183 147 16 18
METOPROLOL TARTRATE 168 158 17 13
ATENOLOL 139 111 18 16
GLIMEPIRIDE 121 75 19 41
LOSARTAN POTASSIUM 121 105 19 19
DONEPEZIL HCL 118 104 21 26
NEXIUM 113 43 22 30
PREDNISONE 113 101 22 33
DIGOXIN 108 84 24 32
CRESTOR 107 76 25 34
CYCLOBENZAPRINE HCL 105 57 R 26 42
MIRTAZAPINE 103 79 27 43
ALLOPURINOL 101 81 28 29
KLOR-CON M10 97 73 29 130
TAMSULOSIN HCL 96 75 30 28
TRAZODONE HCL 94 65 31 48
SERTRALINE HCL 93 91 32 21
ALENDRONATE SODIUM 90 89 33 24
ZOLPIDEM TARTRATE 87 87 34 20
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 66 34 76
CYMBALTA 86 75 36 40
AZITHROMYCIN 83 68 37 47
LOVASTATIN 75 69 38 38
DILTIAZEM ER 70 70 39 109
METHOCARBAMOL 69 32 R 40 202
SULINDAC 68 48 41 212
LOSARTAN-HYDROCHLOROTHIAZIDE 67 67 42 46
KLOR-CON M20 63 51 43 64
HYDROCHLOROTHIAZIDE 61 50 44 11
SYNTHROID 56 47 45 50
CLOPIDOGREL 55 48 46 44
TRIAMTERENE-HYDROCHLOROTHIAZID 53 49 47 140
DIOVAN 52 52 48 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.